Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them Grant US-11603367-B2 United States of America 14 Mar 2023
BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS Application WO-2022185260-A1 World Intellectual Property Organisation (WIPO) 09 Sep 2022